Epidemiologists vanofungidzira kuti vanhu vanopfuura mamirioni zana nemakumi matanhatu pasi rese vakapora kubva kuCOVID-160.Avo vakapora vane hushoma hushoma hwekutapukirwa, zvirwere kana kufa.Kusadzivirirwa kwezvirwere zvakamboitika uku kunodzivirira vanhu vazhinji avo parizvino vasina mushonga.
Kutanga mwedzi uno, World Health Organisation yakapa dhizaini yesainzi ichitaura kuti vanhu vazhinji vanopora kubva kuCOVID-19 vachave nemhinduro yakasimba yekudzivirira.Zvakakosha, vakagumisa kuti mukati memavhiki mana ekutapukirwa, 90% kusvika 99% yevanhu vanopora kubva kuCCIDID-19 vachagadzira masoja ekudzivirira chirwere anotapukira.Pamusoro pezvo, vakagumisa - tichifunga nezvenguva shoma yekutarisa zviitiko - mhinduro yekudzivirira yakaramba yakasimba kweinenge 6 kusvika 8 mwedzi mushure mekutapukirwa.
Ichi chigadziriso chinopindirana neshumo yeNIH muna Ndira 2021: Vanopfuura makumi mapfumbamwe neshanu muzana evanhu vakapora kubva kuCCIDID-95 vane mhinduro yekuzvidzivirira mumuviri ine ndangariro yehutachiona kusvika mwedzi misere mushure mekutapukirwa.National Institutes of Health yakataura zvakare kuti zvakawanikwa izvi "zvinopa tariro" yekuti vanhu vanobaiwa vanozogadzira hutachiona hwekusingaperi.
Saka nei tichitarisisa zvakanyanya kune vaccine-induced immune immune - muchinangwa chedu chekuwana kusadzivirirwa kwemombe, kutarisa kwedu pakufamba, zviitiko zveveruzhinji kana zvakavanzika, kana kushandiswa kwemasks - tichiregeredza kusadzivirirwa kwechisikigo?Ko avo vane dziviriro yechisikigo havafanirewo here kutangazve mabasa “akajairika”?
Masayendisiti mazhinji akaona kuti njodzi yekutapukirwa zvakare yakadzikira, uye kuchipatara uye kufa nekuda kwekutapukirwa zvakare kwakaderera zvakanyanya.Muzvidzidzo zvitanhatu zvinosanganisira vanhu vangangosvika miriyoni imwe zvakaitwa neUnited States, United Kingdom, Denmark, Austria, Qatar, uye United States Marine Corps, kudzikiswa kweCCIDID-19 kudzoreredzwa kwakabva pa82% kusvika 95%.Chidzidzo cheAustria chakawanawo kuti kuwanda kweCCIDIDID-19 kutapukirwazve kwakakonzera chete vanhu vashanu kubva pagumi nemazana mana nemakumi mapfumbamwe nemakumi mana (14,840%) kuti vapinzwe muchipatara, uye munhu mumwe chete pavanhu gumi nevaviri nemazana masere nemakumi mana nevaviri (0.01%) vakafa.
Pamusoro pezvo, data razvino reUS rakaburitswa mushure mekuzivisa kweNIH muna Ndira yakawana kuti masoja ekudzivirira ekudzivirira anogona kugara kusvika mwedzi gumi mushure mekutapukirwa.
Sezvo vagadziri vemitemo yehutano hweveruzhinji vachideredza kusadzivirirwa kwavo kumamiriro ekudzivirira, nhaurirano dzakanyanya kufuratira kuoma kwesimba remuviri revanhu.Kune akatiwandei ekutsvagisa anokurudzira anoratidza kuti masero eropa mumuviri wedu, anonzi "B masero neT masero", anobatsira mukudzivirira masero mushure meCOVID-19.Kana kusadzivirirwa kweSARS-CoV-2 kwakafanana nekwezvimwe zvakakomba hutachiona hwekoronavirus, senge kusadzivirirwa kweSARS-CoV-1, saka dziviriro iyi inogona kugara kwemakore angangoita gumi nemanomwe.Nekudaro, bvunzo dzinoyera kusadzivirirwa kwemaserura dzakaoma uye dzinodhura, izvo zvinoita kuti zviome kuwana uye kudzivirira kushandiswa kwavo mumaitiro ekurapa kana kuongororwa kwehutano hweveruzhinji.
Iyo FDA yakabvumidza akawanda antibody bvunzo.Seyese bvunzo dzese, dzinoda mari uye nguva yekuwana mibairo, uye kuita kwebvunzo yega yega kune mutsauko wakakosha mune izvo zvinomiririrwa neantibody.Musiyano wakakosha ndewekuti kumwe ongororo inongoona masoja ekudzivirira chirwere anowanikwa mushure meutachiona hwega, masoja ekudzivirira chirwere anonzi “N”, nepo mamwe asingakwanise kusiyanisa masoja ekudzivirira chirwere anokonzerwa nejekiseni, “S”.Vanachiremba nevarwere vanofanirwa kutarisisa kune izvi uye kubvunza kuti ndeapi masoja ekudzivirira chirwere anoyerwa nawo.
Svondo rapfuura, Chivabvu 19, FDA yakaburitsa gwaro rekuchengetedza veruzhinji richiti kunyangwe SARS-CoV-2 antibody bvunzo inoita basa rakakosha mukuzivisa vanhu vakafumurwa hutachiona hweSARS-CoV-2 uye vanogona kunge vakagadzira hutachiona hwehutachiona. Kupindura kwechiito, kuongororwa kweantibody hakufanirwe kushandiswa kuona kusadzivirirwa kana kudzivirira kubva kuCOVID-19.Ok?
Kunyange zvazvo zvichikosha kuteerera shoko racho, rinovhiringa.Iyo FDA haina kupa chero data muyambiro uye yakasiya avo vakanyeverwa vasina chokwadi kuti nei kuongororwa kweantibody kusingafanirwe kushandiswa kuona kusadzivirirwa kana kudzivirira kubva kuCOVID-19.Chirevo cheFDA chakaenderera mberi chichiti kuongororwa kweantibody kunofanirwa kushandiswa neavo vane ruzivo mukuongororwa kweantibody.hapana rubatsiro.
Kufanana neakawanda maficha ehurumende yemubatanidzwa mhinduro kuCOVID-19, zvirevo zveFDA zvinosara kumashure kwesainzi.Tichifunga kuti 90% kusvika 99% yevanhu vanopora kubva kuCCIDID-19 vachagadzira masoja ekudzivirira chirwere anotapukira, vanachiremba vanogona kushandisa bvunzo chaiyo kuzivisa vanhu nezve njodzi yavo.Tinogona kuudza varwere kuti vanhu vakapora kubva kuCOVID-19 vane kudzivirirwa kwakasimba, izvo zvinogona kuvadzivirira kubva mukutapukirwa, chirwere, kuchipatara, uye kufa.Muchokwadi, kudzivirira uku kwakafanana kana kuti nani pane vaccine-induced immune immune.Muchidimbu, vanhu vakapora kubva kuhutachiona hwekare kana vane masoja ekudzivirira chirwere vanofanirwa kunzi vakachengetedzwa, zvakafanana nevanhu vakabaiwa.
Tichitarisa kune ramangwana, vagadziri vemitemo vanofanirwa kusanganisira kusadzivirirwa kwechisikigo sekutsanangurwa kwakaringana uye kwakavimbika antibody bvunzo kana zvinyorwa zvehutachiona hwekare (yaimbove yakanaka PCR kana antigen bvunzo) sehumbowo humwe hwekudzivirira sekudzivirira.Dziviriro iyi inofanirwa kunge iine magariro akafanana neanoitwa nejekiseni.Mutemo wakadaro unoderedza zvakanyanya kushushikana uye kuwedzera mikana yekufamba, zviitiko, kushanya kwemhuri, nezvimwe. Iyo yakagadziridzwa mutemo inobvumira avo vakapora kupemberera kupora kwavo nekuvaudza nezvekudzivirirwa kwavo, zvichivabvumira kurasa masks zvakachengeteka, kuratidza zviso zvavo. uye kupinda muuto rakabaiwa.
Jeffrey Klausner, MD, MPH, purofesa wekiriniki yemishonga yekudzivirira paKeck School of Medicine paYunivhesiti yeSouth California, Los Angeles, uye aimbova chiremba weCenters for Disease Control and Prevention.Noah Kojima, MD, chiremba anogara mukurapa kwemukati paYunivhesiti yeCalifornia, Los Angeles.
Klausner ndiye director wezvekurapa wekambani yekuyedza Curative uye akaburitsa muripo weDanaher, Roche, Cepheid, Abbott uye Phase Scientific.Akambowana mari kubva kuNIH, CDC, uye vagadziri vebvunzo vakazvimiririra uye makambani emishonga kuti vatsvage nzira nyowani dzekuona nekurapa zvirwere zvinotapukira.
Zvishandiso zviri pawebhusaiti ino ndezvekutarisa chete uye hazvisi zvinotsiva zano rekurapa, kuongororwa kana kurapwa kunopihwa nevanopa hutano hwehutano.© 2021 MedPage Nhasi, LLC.kodzero dzose dzakachengetedzwa.Medpage Nhasi ndeimwe yemubatanidzwa akanyoreswa zviratidzo zveMedPage Nhasi, LLC uye haigone kushandiswa nevechitatu mapato pasina mvumo.
Nguva yekutumira: Jun-25-2021